Physician profile
Jeffrey G Carr
NPI 1649260373
$1,886,392.90
in general payments reported to CMS, 2019-2025
56 companies · $16K in 2025
The $16K reported for 2025 was more than what 91% of Interventional Cardiology providers received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $123K · 2020: $67K · 2021: $1.5M · 2022: $68K · 2023: $73K · 2024: $24K · 2025: $16K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $86K · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $10K · Acquisitions: $8,289 · Food and Beverage: $6,647 · Travel and Lodging: $1,612.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $85,540.00 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $10,450.00 |
| Acquisitions | $8,289.32 |
| Food and Beverage | $6,647.36 |
| Travel and Lodging | $1,611.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bard Peripheral Vascular, INC. | $1,620,834.33 | 2019-2025 | Venclose Maven Catheter, Rotarexs 6 F X 135 Cm, Venovo |
| Medtronic Vascular, INC. | $80,026.18 | 2019-2020 | |
| Philips North America LLC | $61,737.03 | 2019-2024 | (9520) Igt Devices Undivided |
| Medtronic, INC. | $41,234.01 | 2021-2025 | In.Pact Admiral, Hawkone, Turbohawk |
| Venclose INC. | $38,098.99 | 2019-2020 | |
| Abbott Laboratories | $21,625.94 | 2020-2024 | Esprit |
| Cordis US Corp. | $5,579.07 | 2023-2025 | Mynx Control Venous, Brite Tip, Selution Slr Pta |
| W. L. Gore & Associates, INC. | $4,427.66 | 2019 | |
| Boston Scientific Corporation | $3,785.42 | 2019-2025 | Ekosonic, Varithena Administration Pack |
| Intact Vascular, INC. | $2,094.23 | 2019 | |
| Cardiovascular Systems INC. | $772.25 | 2019-2023 | Diamondback Coronary |
| Janssen Pharmaceuticals, INC | $723.20 | 2019-2024 | Xarelto |
| Avinger INC. | $611.75 | 2019-2023 | Pantheris |
| Shockwave Medical, INC | $450.83 | 2024-2025 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Angiodynamics, INC. | $446.96 | 2022-2024 | Auryon Laser System 100-120 Vac |
Show all 53 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $399.47 | 2019-2024 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $321.95 | 2019-2024 | Lifevest |
| Merck Sharp & Dohme LLC | $321.49 | 2021-2024 | Verquvo |
| Biotronik INC. | $269.66 | 2020-2022 | |
| Inspiremd Ltd | $257.14 | 2024-2025 | Cguard Prime Carotid Stent System, Cguard |
| Heartflow, INC. | $202.52 | 2021-2024 | Ffrct |
| E.R. Squibb & Sons, L.L.C. | $181.32 | 2019-2024 | Camzyos, Eliquis |
| Amgen INC. | $170.29 | 2019-2022 | |
| Abiomed | $146.84 | 2022-2025 | |
| Vasorum USA INC. | $138.28 | 2023 | Celt Acd |
| Penumbra, INC. | $136.24 | 2022 | |
| Ablative Solutions, INC. | $133.51 | 2022 | |
| Gilead Sciences, INC. | $110.77 | 2019 | |
| Endologix LLC | $99.40 | 2024 | Torus Stent Graft System, Endocross Device |
| Reflow Medical INC | $97.06 | 2024 | |
| Cardiva Medical, INC. | $91.62 | 2022-2023 | Cardiva Vascade Mvp Vvcs 6-12f |
| Novo Nordisk INC | $91.23 | 2022-2023 | Ozempic, Rybelsus |
| Astellas Pharma US INC | $81.90 | 2019-2021 | |
| Sanofi-Aventis U.S. LLC | $76.77 | 2019-2024 | |
| Alnylam Pharmaceuticals INC. | $75.90 | 2021-2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $70.10 | 2020-2023 | Jardiance |
| Atricure, INC. | $68.75 | 2022 | |
| Cvrx, INC. | $55.26 | 2022 | |
| Astrazeneca Pharmaceuticals Lp | $53.94 | 2019-2024 | Farxiga |
| Irhythm Technologies, INC. | $30.90 | 2022-2024 | Zio Xt Patch, Zio Monitor |
| Veryan Medical Incorporated | $29.55 | 2021 | |
| Siemens Medical Solutions USA, INC. | $27.70 | 2023-2024 | Artis Icono Biplane, Artis Icono Floor |
| Lundbeck LLC | $27.26 | 2019-2021 | |
| Acist Medical Systems, INC. | $24.26 | 2019 | |
| Esperion Therapeutics, INC. | $23.19 | 2020 | |
| Cardinal Health 200 LLC | $22.89 | 2021 | |
| Becton, Dickinson and Company | $21.00 | 2023 | |
| Kiniksa Pharmaceuticals International, Plc | $15.75 | 2024 | Arcalyst |
| Asahi Intecc USA, INC. | $15.37 | 2022 | |
| Lexicon Pharmaceuticals, INC. | $14.59 | 2023 | Inpefa |
| Cmp Pharma, INC. | $14.27 | 2022 | |
| Amarin Pharma, INC. | $13.69 | 2021 | |
| Pfizer INC. | $13.22 | 2023 |
3 companies reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$800,002.00 in ownership or investment interests, as reported to CMS. These are holdings a clinician or an immediate family member has in a company, not payments received.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jeffrey Carr listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.